Stock Analysis

Kazan Organichesky sintez (MCX:KZOS) Might Be Having Difficulty Using Its Capital Effectively

MISX:KZOS
Source: Shutterstock

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. So while Kazan Organichesky sintez (MCX:KZOS) has a high ROCE right now, lets see what we can decipher from how returns are changing.

Return On Capital Employed (ROCE): What is it?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Kazan Organichesky sintez, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.31 = ₽24b ÷ (₽84b - ₽6.1b) (Based on the trailing twelve months to June 2021).

Therefore, Kazan Organichesky sintez has an ROCE of 31%. In absolute terms that's a great return and it's even better than the Chemicals industry average of 22%.

Check out our latest analysis for Kazan Organichesky sintez

roce
MISX:KZOS Return on Capital Employed November 23rd 2021

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you want to delve into the historical earnings, revenue and cash flow of Kazan Organichesky sintez, check out these free graphs here.

What The Trend Of ROCE Can Tell Us

On the surface, the trend of ROCE at Kazan Organichesky sintez doesn't inspire confidence. While it's comforting that the ROCE is high, five years ago it was 49%. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. If these investments prove successful, this can bode very well for long term stock performance.

On a related note, Kazan Organichesky sintez has decreased its current liabilities to 7.3% of total assets. So we could link some of this to the decrease in ROCE. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Since the business is basically funding more of its operations with it's own money, you could argue this has made the business less efficient at generating ROCE.

The Key Takeaway

In summary, despite lower returns in the short term, we're encouraged to see that Kazan Organichesky sintez is reinvesting for growth and has higher sales as a result. And long term investors must be optimistic going forward because the stock has returned a huge 212% to shareholders in the last five years. So while investors seem to be recognizing these promising trends, we would look further into this stock to make sure the other metrics justify the positive view.

One more thing: We've identified 3 warning signs with Kazan Organichesky sintez (at least 1 which is a bit unpleasant) , and understanding these would certainly be useful.

If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity.

Valuation is complex, but we're here to simplify it.

Discover if Kazan Organichesky sintez might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About MISX:KZOS

Kazan Organichesky sintez

Kazan Public Joint Stock Company Organichesky sintez, together with its subsidiaries, produces and sells chemical products in Russia.

Flawless balance sheet and fair value.